{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:24:13Z","timestamp":1785522253547,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04373-1","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:23:48Z","timestamp":1780039428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relationship of prognostic nutritional index with clinical outcomes and survival in idiopathic pulmonary fibrosis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6991-8181","authenticated-orcid":false,"given":"Nurcan","family":"Guler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5711-1372","authenticated-orcid":false,"given":"Aylin Ozgen","family":"Alpaydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-5637","authenticated-orcid":false,"given":"Kemal Can","family":"Tertemiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3691-9150","authenticated-orcid":false,"given":"Can","family":"Sevinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-061X","authenticated-orcid":false,"given":"Hulya","family":"Ellidokuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2724-0616","authenticated-orcid":false,"given":"Gok\u00e7en Omero\u011flu","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7341-654X","authenticated-orcid":false,"given":"Eyup Sabri","family":"Ucan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"9","key":"4373_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347.","journal-title":"Am J Respir Crit Care Med"},{"key":"4373_CR2","doi-asserted-by":"crossref","unstructured":"Podolanczuk AJ, Thomson CC, Remy-Jardin M, Richeldi L, Martinez FJ, Kolb M, et al. Idiopathic pulmonary fibrosis: state of the art for 2023. 2023;61(4):2200957.","DOI":"10.1183\/13993003.00957-2022"},{"issue":"1","key":"4373_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1378\/chest.10-2572","volume":"140","author":"SD Nathan","year":"2011","unstructured":"Nathan SD, Shlobin OA, Weir N, Ahmad S, Kaldjob JM, Battle E, et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest. 2011;140(1):221\u20139.","journal-title":"Chest"},{"issue":"11 Suppl","key":"4373_CR4","first-page":"S176","volume":"23","author":"R Sharif","year":"2017","unstructured":"Sharif R. Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines. Am J Manag Care. 2017;23(11 Suppl):S176\u201382.","journal-title":"Am J Manag Care"},{"issue":"6","key":"4373_CR5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/ph17060709","volume":"17","author":"M Chianese","year":"2024","unstructured":"Chianese M, Screm G, Salton F, Confalonieri P, Trotta L, Barbieri M, et al. Pirfenidone and nintedanib in pulmonary fibrosis: lights and shadows. Pharmaceuticals (Basel). 2024;17(6):709.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"4373_CR6","doi-asserted-by":"publisher","first-page":"e29266","DOI":"10.1016\/j.heliyon.2024.e29266","volume":"10","author":"J Liu","year":"2024","unstructured":"Liu J, Wang F, Hong Y, Luo F. Bibliometric analysis of the pirfenidone and nintedanib in interstitial lung diseases. Heliyon. 2024;10(8):e29266.","journal-title":"Heliyon"},{"issue":"7","key":"4373_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3390\/jcm10071427","volume":"10","author":"SD Nathan","year":"2021","unstructured":"Nathan SD, Mehta J, Stauffer J, Morgenthien E, Yang M, Limb SL, et al. Changes in Neutrophil\u2013Lymphocyte or Platelet\u2013Lymphocyte Ratios and Their Associations with Clinical Outcomes in Idiopathic Pulmonary Fibrosis. J Clin Med. 2021;10(7):1427.","journal-title":"J Clin Med"},{"issue":"1","key":"4373_CR8","first-page":"e78319","volume":"17","author":"D Ay","year":"2025","unstructured":"Ay D, Ba\u015fl\u0131lar \u015e, Kulah G, Kaan Saylan B, Kalbaran Kismet G, Okutan O. Blood Cell Counts and Inflammatory Indexes in Idiopathic Pulmonary Fibrosis. Cureus. 2025;17(1):e78319.","journal-title":"Cureus"},{"key":"4373_CR9","doi-asserted-by":"publisher","first-page":"676569","DOI":"10.3389\/fmolb.2021.676569","volume":"8","author":"G Ishikawa","year":"2021","unstructured":"Ishikawa G, Liu A, Herzog EL. Evolving Perspectives on Innate Immune Mechanisms of IPF. Front Mol Biosci. 2021;8:676569.","journal-title":"Front Mol Biosci"},{"issue":"19","key":"4373_CR10","doi-asserted-by":"publisher","first-page":"5874","DOI":"10.3390\/jcm13195874","volume":"13","author":"F Bozku\u015f","year":"2024","unstructured":"Bozku\u015f F, Keskin O. The Prognostic Role of Advanced Lung Cancer Inflammation Index in Patients with Idiopathic Pulmonary Fibrosis. J Clin Med. 2024;13(19):5874.","journal-title":"J Clin Med"},{"issue":"10","key":"4373_CR11","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.3390\/jcm13102825","volume":"13","author":"Y Iwanami","year":"2024","unstructured":"Iwanami Y, Ebihara K, Nakao K, Kubo R, Miyagi M, Nakamura Y, et al. Impact of Controlling Nutritional Status Score on Mortality in Elderly Patients with Idiopathic Pulmonary Fibrosis. J Clin Med. 2024;13(10):2825.","journal-title":"J Clin Med"},{"issue":"8","key":"4373_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/resp.14523","volume":"28","author":"Y Mochizuka","year":"2023","unstructured":"Mochizuka Y, Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, et al. Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. Respirology. 2023;28(8):775\u201383.","journal-title":"Respirology"},{"issue":"1","key":"4373_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12957-016-0920-7","volume":"14","author":"T Mohri","year":"2016","unstructured":"Mohri T, Mohri Y, Shigemori T, Takeuchi K, Itoh Y, Kato T. Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer. World J Surg Oncol. 2016;14(1):170.","journal-title":"World J Surg Oncol"},{"key":"4373_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cca.2018.08.030","volume":"486","author":"Z Wang","year":"2018","unstructured":"Wang Z, Wang Y, Zhang X, Zhang T. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis. Clin Chim Acta. 2018;486:303\u201310.","journal-title":"Clin Chim Acta"},{"key":"4373_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijsu.2019.05.018","volume":"67","author":"X Wang","year":"2019","unstructured":"Wang X, Wang Y. The prognostic nutritional index is prognostic factor of gynecological cancer: A systematic review and meta-analysis. Int J Surg. 2019;67:79\u201386.","journal-title":"Int J Surg"},{"issue":"1","key":"4373_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s41043-024-00709-x","volume":"43","author":"K Cao","year":"2024","unstructured":"Cao K, Miao X, Chen X. Association of inflammation and nutrition-based indicators with chronic obstructive pulmonary disease and mortality. J Health Popul Nutr. 2024;43(1):209.","journal-title":"J Health Popul Nutr"},{"key":"4373_CR17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2147\/COPD.S385374","volume":"18","author":"E Suzuki","year":"2023","unstructured":"Suzuki E, Kawata N, Shimada A, Sato H, Anazawa R, Suzuki M, et al. Prognostic Nutritional Index (PNI) as a Potential Prognostic Tool for Exacerbation of COPD in Elderly Patients. Int J Chron Obstruct Pulmon Dis. 2023;18:1077\u201390.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"4373_CR18","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"4373_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"1","key":"4373_CR20","doi-asserted-by":"publisher","first-page":"1600016","DOI":"10.1183\/13993003.00016-2016","volume":"49","author":"BL Graham","year":"2017","unstructured":"Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, et al. 2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016.","journal-title":"Eur Respir J"},{"issue":"10","key":"4373_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, et al. A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis. Ann Intern Med. 2012;156(10):684\u201391.","journal-title":"Ann Intern Med"},{"issue":"1","key":"4373_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0002-9610(80)90246-9","volume":"139","author":"GP Buzby","year":"1980","unstructured":"Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980;139(1):160\u20137.","journal-title":"Am J Surg"},{"issue":"4","key":"4373_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/nu12041131","volume":"12","author":"P Faverio","year":"2020","unstructured":"Faverio P, Bocchino M, Caminati A, Fumagalli A, Gasbarra M, Iovino P, et al. Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions. Nutrients. 2020;12(4):1131.","journal-title":"Nutrients"},{"key":"4373_CR24","doi-asserted-by":"publisher","first-page":"107774","DOI":"10.1016\/j.rmed.2024.107774","volume":"233","author":"Q Shen","year":"2024","unstructured":"Shen Q, Zhou S, Song M, Ouyang X, Tan Y, Peng Y, et al. Prevalence and prognostic value of malnutrition in patients with IPF using three scoring systems. Respir Med. 2024;233:107774.","journal-title":"Respir Med"},{"issue":"6","key":"4373_CR25","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.clnu.2022.05.001","volume":"41","author":"S Jouneau","year":"2022","unstructured":"Jouneau S, Rousseau C, Lederlin M, Lescoat A, Kerjouan M, Chauvin P, et al. Malnutrition and decreased food intake at diagnosis are associated with hospitalization and mortality of idiopathic pulmonary fibrosis patients. Clin Nutr. 2022;41(6):1335\u201342.","journal-title":"Clin Nutr"},{"issue":"S3","key":"4373_CR26","doi-asserted-by":"publisher","first-page":"S408","DOI":"10.21037\/jtd.2018.11.118","volume":"11","author":"F Shoji","year":"2019","unstructured":"Shoji F. Clinical impact of preoperative immunonutritional status in patients undergoing surgical resection of lung cancer. J Thorac Dis. 2019;11(S3):S408\u201312.","journal-title":"J Thorac Dis"},{"issue":"5","key":"4373_CR27","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s00520-019-05055-x","volume":"28","author":"Y Bozkaya","year":"2020","unstructured":"Bozkaya Y, K\u00f6stek O, Sakin A, \u00d6zy\u00fckseler DT, \u015eakalar T, \u00c7il \u0130. Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy? Support Care Cancer. 2020;28(5):2273\u201382.","journal-title":"Support Care Cancer"},{"key":"4373_CR28","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.2147\/CMAR.S248034","volume":"12","author":"Y Ozdemir","year":"2020","unstructured":"Ozdemir Y, Topkan E, Mertsoylu H, Selek U. Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy. Cancer Manag Res. 2020;12:1959\u201367.<\\\/p>","journal-title":"Cancer Manag Res"},{"key":"4373_CR29","doi-asserted-by":"publisher","unstructured":"Zhang Q, Bao J, Zhu ZY, Jin MX. Prognostic nutritional index as a prognostic factor in lung cancer patients receiving chemotherapy: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25(18):5636\u201352. https:\/\/doi.org\/10.26355\/eurrev_202109_26783.","DOI":"10.26355\/eurrev_202109_26783"},{"issue":"8","key":"4373_CR30","doi-asserted-by":"publisher","first-page":"e17400","DOI":"10.1016\/j.heliyon.2023.e17400","volume":"9","author":"H Xia","year":"2023","unstructured":"Xia H, Zhang W, Zheng Q, Zhang Y, Mu X, Wei C, et al. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Heliyon. 2023;9(8):e17400.","journal-title":"Heliyon"},{"key":"4373_CR31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2147\/COPD.S385374","volume":"18","author":"E Suzuki","year":"2023","unstructured":"Suzuki E, Kawata N, Shimada A, Sato H, Anazawa R, Suzuki M, et al. Prognostic Nutritional Index (PNI) as a Potential Prognostic Tool for Exacerbation of COPD in Elderly Patients. Int J Chron Obstruct Pulmon Dis. 2023;18:1077\u201390.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"4373_CR32","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.21037\/jtd-20-803","volume":"12","author":"Y Hachisu","year":"2020","unstructured":"Hachisu Y, Murata K, Takei K, Tsuchiya T, Tsurumaki H, Koga Y, et al. Prognostic nutritional index as a predictor of mortality in nontuberculous mycobacterial lung disease. J Thorac Dis. 2020;12(6):3101\u20139.","journal-title":"J Thorac Dis"},{"key":"4373_CR33","doi-asserted-by":"publisher","first-page":"107774","DOI":"10.1016\/j.rmed.2024.107774","volume":"233","author":"Q Shen","year":"2024","unstructured":"Shen Q, Zhou S, Song M, Ouyang X, Tan Y, Peng Y, et al. Prevalence and prognostic value of malnutrition in patients with IPF using three scoring systems. Respir Med. 2024;233:107774.","journal-title":"Respir Med"},{"issue":"1","key":"4373_CR34","doi-asserted-by":"publisher","first-page":"17842","DOI":"10.1038\/s41598-024-68754-4","volume":"14","author":"E Chung","year":"2024","unstructured":"Chung E, Woo A, Yong SH, Park Y, Lee SH, Kim SY, et al. Malnutrition is associated with mortality in Sj\u00f6gren\u2019s syndrome-associated interstitial lung disease. Sci Rep. 2024;14(1):17842.","journal-title":"Sci Rep"},{"issue":"22","key":"4373_CR35","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L du Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. N Engl J Med. 2014;370(22):2071\u201382.","journal-title":"N Engl J Med"},{"issue":"1","key":"4373_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1183\/13993003.00026-2015","volume":"47","author":"PW du Noble","year":"2016","unstructured":"Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, et al. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Eur Respir J. 2016;47(1):243\u201353.","journal-title":"Eur Respir J"},{"key":"4373_CR37","doi-asserted-by":"publisher","unstructured":"Cheng Y-Y, Lin S-Y, Chang S-T, Lin C-H, Fu P-K. Cardiopulmonary Exercise Test, mMRC and GAP score Can Predict 1-year Mortality in Patients with Idiopathic Pulmonary Fibrosis: A Prospective Study. Preprint. Research Square. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-192679\/v1.","DOI":"10.21203\/rs.3.rs-192679\/v1"},{"issue":"12","key":"4373_CR38","doi-asserted-by":"publisher","first-page":"8338","DOI":"10.21037\/jtd-23-1908","volume":"16","author":"X Sun","year":"2024","unstructured":"Sun X, Lei S, Zhao H, Guo L, Wang Y. Mortality-related risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analysis. J Thorac Dis. 2024;16(12):8338\u201349.","journal-title":"J Thorac Dis"},{"issue":"2","key":"4373_CR39","first-page":"e2024021","volume":"41","author":"G Polat","year":"2024","unstructured":"Polat G, \u00d6zdemir \u00d6, Ermin S, Ser\u00e7e Unat D, Demirci \u00dc\u00e7sular F. Predictive factors of mortality in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a novel prognostic scoring system. Sarcoidosis Vasc Diffuse Lung Dis. 2024;41(2):e2024021.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"4373_CR40","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1183\/09031936.00014814","volume":"44","author":"U Costabel","year":"2014","unstructured":"Costabel U, Albera C, Lancaster LH. et alSafety and tolerability of pirfenidone in idiopathic pulmonary fibrosis: pooled analysis of clinical trials. Eur Respir J. 2014;44(3):791\u2013800.","journal-title":"Eur Respir J"},{"key":"4373_CR41","first-page":"97","volume":"137","author":"S Harari","year":"2018","unstructured":"Harari S, Caminati A, Albera C, et al. Pirfenidone for idiopathic pulmonary fibrosis: real-life experience from a national registry. Respir Med. 2018;137:97\u2013104.","journal-title":"Respir Med"},{"issue":"4","key":"4373_CR42","first-page":"538","volume":"27","author":"K Norman","year":"2008","unstructured":"Norman K, Pichard C, Lochs H, Pirlich M. Malnutrition affects tolerance to drug treatment. Clin Nutr. 2008;27(4):538\u201343.","journal-title":"Clin Nutr"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04373-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04373-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04373-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:13:15Z","timestamp":1785517995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04373-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4373"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04373-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of Dokuz Eylul Un\u0131versity Faculty of Medicine (Approval number: 2022\/17\u201323) and was conducted in accordance with the Declaration of Helsinki. This study was conducted retrospectively at a university hospital. Permission for the use of patient data was obtained from the hospital administration. Since the study involved only anonymized retrospective data and did not include any intervention, additional informed consent from individual patients was not required according to institutional policies and national regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"335"}}